|Description||Midodrine is a Alpha adrenergic receptor under the development of Shire for the treatment of dysautonomia and orthostatic hypotension. In August 2010, the FDA proposed withdrawing this approval because Shire has failed to complete required studies after the medicine reached the market. In September 2011, Shire announced that it was continuing the process to work with the FDA towards a final approval of the drug.|
|Synonyms||Amatine, ProAmatine, Gutron, ST-1085;2-amino-N-[2-(2,5-dimethoxyphenyl)-2-hydroxyethyl]acetamide; 3092-17-9(hydrochloride)|
|Solubility||Soluble in DMSO|
|Application||dysautonomia and orthostatic hypotension|
|Quality Standard||In-house standard|
|Shelf Life||2 month in rt, long time|
|Current Developer||Myungmoon Pharm; Shire; Shire Pharmaceuticals Group; Taisho Pharmaceutical|
Fenoterol hydrochloride is a β2 adrenoreceptor agonist used as a bronchodilator for the treatment and prophylaxis of reversible bronchospasm, administered by in...
Guanoxabenz, a metabolite of guanaben, is an α2 adrenergic receptor agonist.
Tolazoline is a non-selective competitive α-adrenergic receptor antagonist.
Amezinium methylsulfate, a sympathomimetic drug used for the treatment of low blood pressure, increases the arterial blood pressure and heart rate of anaestheti...
MK-351 hydrochloride is an alpha-adrenergic agonist selective for α2-adrenergic receptors. It is a psychoactive drug used as a sympatholytic or antihypertensive...
P2647, also known as Benzquinamide, is a discontinued antiemetic compound with antihistaminic, mild anticholinergic, and sedative properties. P2647 binds to the...
Landiolol is an ultra-short-acting Beta 1 adrenergic receptor antagonist using for managing supraventricular tachyarrhythmias in sepsis. It is also used as an a...
Methyldopa (Aldomet) is a DOPA decarboxylase competitive inhibitor with an ED50 of 21.8 mg/kg.
Prazosin HCl, a quinazoline derivative, is the first of a new chemical class of antihypertensives.
Metaraminol is a stereoisomer of meta-hydroxynorephedrine, acts as An adrenergic agonist that increases both systolic and diastolic blood pressure.
GYKI-16084 is a postsynaptic alpha2-blocker with the potential to treat benign prostatic hyperplasia.
Guanabenz Acetate is an selective agonist of α2a-adrenergic receptor, α2b-adrenergic receptor and α2c-adrenergic receptor with pEC50 of 8.25, 7.01 and ~5, respe...
Fenoterol, a phenol derivative, is a β2-adrenoceptor agonist and could be used as a bronchodilator and an antiasthmatic.
Procaterol hydrochloride is a long-acting, very potent and specific beta-2-adrenergic receptor agonist. It acts as a vasodialator for long term treatment of ast...
Levobetaxolol exhibits a higher affinity at cloned human β1 and β2 receptors with Ki value of 0.76 nM and 32.6 nM, respectively.
Pirbuterol acetate is a short-acting β2 adrenoreceptor agonist. It has bronchodilating action and is used as a bronchodilator. It is also used in the treatment ...
Fenoterol hydrobromide is a β2-adrenergic agonist agent used for asthma and chronic obstructive pulmonary disease treatment. It has already been approved for us...
ICI141292, also known as Epanolol, is a adrenergic β-antagonist with a greater affinity for β1- than β2-adrenoceptors, which is used for treatment of hypertensi...
BMS-196085, a sulfanilamide derivative, has been found to be a β-adrenergic receptor agonist that was once studied in obesity as well as yype 2 diabetes mellitu...
Pindolol, an Indole derivative, could be used in the treatment of hypertension and arrhythmia for acting as a 5-HT1A/1B receptor antagonist. IC50: 33nM(Ki).